Exact Mass: 257.1627

Exact Mass Matches: 257.1627

Found 63 metabolites which its exact mass value is equals to given mass value 257.1627, within given mass tolerance error 0.001 dalton. Try search metabolite list with more accurate mass tolerance error 0.0002 dalton.

2-Hexenoylcarnitine

3-[(2E)-hex-2-enoyloxy]-4-(trimethylazaniumyl)butanoate

C13H23NO4 (257.1627)


2-Hexenoylcarnitine is an acylcarnitine. More specifically, it is an 2-hexenoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy.  This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 2-Hexenoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 2-hexenoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. In particular 2-hexenoylcarnitine is elevated in the blood or plasma of individuals with obesity in aldolenscens  (PMID: 26910390). It is also decreased in the blood or plasma of individuals with adolescent idiopathic scoliosis (PMID: 26928931). Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews]. A human metabolite taken as a putative food compound of mammalian origin [HMDB]

   

4-Hexenoylcarnitine

3-(hex-4-enoyloxy)-4-(trimethylazaniumyl)butanoate

C13H23NO4 (257.1627)


4-Hexenoylcarnitine is an acylcarnitine. More specifically, it is an hex-4-enoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 4-Hexenoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 4-Hexenoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. In particular 4-Hexenoylcarnitine is elevated in the blood or plasma of individuals with obesity in aldolenscens (PMID: 26910390). It is also decreased in the blood or plasma of individuals with adolescent idiopathic scoliosis (PMID: 26928931). Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

(3E)-Hexenoylcarnitine

3-(hex-3-enoyloxy)-4-(trimethylazaniumyl)butanoate

C13H23NO4 (257.1627)


(3E)-Hexenoylcarnitine is an acylcarnitine. More specifically, it is an (3E)-hex-3-enoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. (3E)-Hexenoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine (3E)-Hexenoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. In particular (3E)-Hexenoylcarnitine is elevated in the blood or plasma of individuals with obesity in aldolenscens (PMID: 26910390). It is also decreased in the blood or plasma of individuals with adolescent idiopathic scoliosis (PMID: 26928931). Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

Hexenoylcarnitine

3-hydroxy-4-oxo-3-[(trimethylazaniumyl)methyl]non-5-enoate

C13H23NO4 (257.1627)


   
   

3-(2-methylbutyryloxy)tropan-6,7-diol

3-(2-methylbutyryloxy)tropan-6,7-diol

C13H23NO4 (257.1627)


   

CAR 6:1

3-[(2E)-hex-2-enoyloxy]-4-(trimethylazaniumyl)butanoate

C13H23NO4 (257.1627)


   

N-(3-hydroxy-7-methyloctanoyl)homoserine lactone

N-(3-hydroxy-7-methyloctanoyl)homoserine lactone

C13H23NO4 (257.1627)


   

2-(dimethylamino)ethyl 2-methylprop-2-enoate,methyl 2-methylprop-2-enoate

2-(dimethylamino)ethyl 2-methylprop-2-enoate,methyl 2-methylprop-2-enoate

C13H23NO4 (257.1627)


   

N-Boc-4-Piperidinepropionic Acid

N-Boc-4-Piperidinepropionic Acid

C13H23NO4 (257.1627)


   

Boc-L-Cyclopentylalanine

Boc-L-Cyclopentylalanine

C13H23NO4 (257.1627)


   

(R)-TERT-BUTYL 3-(2-METHOXY-2-OXOETHYL)PIPERIDINE-1-CARBOXYLATE

(R)-TERT-BUTYL 3-(2-METHOXY-2-OXOETHYL)PIPERIDINE-1-CARBOXYLATE

C13H23NO4 (257.1627)


   

Boc-1-aminomethyl-cyclohexane carboxylic acid

Boc-1-aminomethyl-cyclohexane carboxylic acid

C13H23NO4 (257.1627)


   

1-(TERT-BUTOXYCARBONYL)-3-ETHYLPIPERIDINE-3-CARBOXYLIC ACID

1-(TERT-BUTOXYCARBONYL)-3-ETHYLPIPERIDINE-3-CARBOXYLIC ACID

C13H23NO4 (257.1627)


   

3-(2-Carboxyethyl)piperidine-1-carboxylic acid tert-butyl ester

3-(2-Carboxyethyl)piperidine-1-carboxylic acid tert-butyl ester

C13H23NO4 (257.1627)


   

Boc-a-Propyl-DL-proline

Boc-a-Propyl-DL-proline

C13H23NO4 (257.1627)


   

1-(TERT-BUTOXYCARBONYL)-2-METHYLAZEPANE-2-CARBOXYLIC ACID

1-(TERT-BUTOXYCARBONYL)-2-METHYLAZEPANE-2-CARBOXYLIC ACID

C13H23NO4 (257.1627)


   

1-(tert-Butoxycarbonyl)-4-methylazepane-4-carboxylic acid

1-(tert-Butoxycarbonyl)-4-methylazepane-4-carboxylic acid

C13H23NO4 (257.1627)


   

1-(TERT-BUTOXYCARBONYL)-6,6-DIMETHYLPIPERIDINE-3-CARBOXYLIC ACID

1-(TERT-BUTOXYCARBONYL)-6,6-DIMETHYLPIPERIDINE-3-CARBOXYLIC ACID

C13H23NO4 (257.1627)


   

Tert-butoxycarbonylamino-cyclohexyl-acetic acid

Tert-butoxycarbonylamino-cyclohexyl-acetic acid

C13H23NO4 (257.1627)


   

Ethyl 1-Boc-3-piperidinecarboxylate

Ethyl 1-Boc-3-piperidinecarboxylate

C13H23NO4 (257.1627)


   

1-Boc-4-(oxiran-2-ylmethyl)-4-hydroxypiperidine

1-Boc-4-(oxiran-2-ylmethyl)-4-hydroxypiperidine

C13H23NO4 (257.1627)


   

N,N-Bis-Boc-N-Allylamine

N,N-Bis-Boc-N-Allylamine

C13H23NO4 (257.1627)


   

trans-(N-Boc-4-aminocyclohexyl)acetic Acid

trans-(N-Boc-4-aminocyclohexyl)acetic Acid

C13H23NO4 (257.1627)


   

2-(2-Carboxyethyl)piperidine-1-carboxylic acid tert-butyl ester

2-(2-Carboxyethyl)piperidine-1-carboxylic acid tert-butyl ester

C13H23NO4 (257.1627)


   

1-tert-Butoxycarbonylamino-cycloheptanecarboxylic acid

1-tert-Butoxycarbonylamino-cycloheptanecarboxylic acid

C13H23NO4 (257.1627)


   

(E)-METHYL 3-(2-((TERT-BUTYLDIMETHYLSILYLOXY)-METHYL)FURO[3,2-B]PYRIDIN-6-YL)ACRYLATE

(E)-METHYL 3-(2-((TERT-BUTYLDIMETHYLSILYLOXY)-METHYL)FURO[3,2-B]PYRIDIN-6-YL)ACRYLATE

C13H23NO4 (257.1627)


   

boc-tranexamic acid

boc-tranexamic acid

C13H23NO4 (257.1627)


   
   

(r)-2-tert-butoxycarbonylamino-3-cyclopentyl-propionic acid

(r)-2-tert-butoxycarbonylamino-3-cyclopentyl-propionic acid

C13H23NO4 (257.1627)


   

TERT-BUTYL 2-(2-METHOXY-2-OXOETHYL)PIPERAZINE-1-CARBOXYLATE

TERT-BUTYL 2-(2-METHOXY-2-OXOETHYL)PIPERAZINE-1-CARBOXYLATE

C13H23NO4 (257.1627)


   
   

tert-butyl 2-(hydroxymethyl)-1-oxa-7-azaspiro[3.5]nonane-7-carboxylate

tert-butyl 2-(hydroxymethyl)-1-oxa-7-azaspiro[3.5]nonane-7-carboxylate

C13H23NO4 (257.1627)


   

N-Boc-1-Oxa-8-azaspiro[4.5]decan-3-ol

N-Boc-1-Oxa-8-azaspiro[4.5]decan-3-ol

C13H23NO4 (257.1627)


   

(S)-TERT-BUTYL 2-(2-METHOXY-2-OXOETHYL)PIPERIDINE-1-CARBOXYLATE

(S)-TERT-BUTYL 2-(2-METHOXY-2-OXOETHYL)PIPERIDINE-1-CARBOXYLATE

C13H23NO4 (257.1627)


   

Ethyl (1S,2R)-2-(Boc-amino)cyclopentanecarboxylate

Ethyl (1S,2R)-2-(Boc-amino)cyclopentanecarboxylate

C13H23NO4 (257.1627)


   

Ethyl (1R,2S)-2-(Boc-amino)cyclopentanecarboxylate

Ethyl (1R,2S)-2-(Boc-amino)cyclopentanecarboxylate

C13H23NO4 (257.1627)


   

2-(cis-4-((tert-Butoxycarbonyl)amino)cyclohexyl)acetic acid

2-(cis-4-((tert-Butoxycarbonyl)amino)cyclohexyl)acetic acid

C13H23NO4 (257.1627)


   

1-tert-butyl 3-ethyl piperidine-1,3-dicarboxylate

1-tert-butyl 3-ethyl piperidine-1,3-dicarboxylate

C13H23NO4 (257.1627)


   

3-(TERT-BUTOXYCARBONYL(CYCLOPENTYL)AMINO)PROPANOICACID

3-(TERT-BUTOXYCARBONYL(CYCLOPENTYL)AMINO)PROPANOICACID

C13H23NO4 (257.1627)


   

3-(1-(tert-Butoxycarbonyl)piperidin-4-yl)propanoic acid

3-(1-(tert-Butoxycarbonyl)piperidin-4-yl)propanoic acid

C13H23NO4 (257.1627)


   

1-O-tert-butyl 2-O-methyl 2-methylpiperidine-1,2-dicarboxylate

1-O-tert-butyl 2-O-methyl 2-methylpiperidine-1,2-dicarboxylate

C13H23NO4 (257.1627)


   

tert-butyl 4-(2-methoxy-2-oxo-ethyl)piperidine-1-carboxylate

tert-butyl 4-(2-methoxy-2-oxo-ethyl)piperidine-1-carboxylate

C13H23NO4 (257.1627)


   

1-O-tert-butyl 3-O-methyl 6-methylpiperidine-1,3-dicarboxylate

1-O-tert-butyl 3-O-methyl 6-methylpiperidine-1,3-dicarboxylate

C13H23NO4 (257.1627)


   

tert-butyl 3-(2-ethoxy-2-oxoethyl)pyrrolidine-1-carboxylate

tert-butyl 3-(2-ethoxy-2-oxoethyl)pyrrolidine-1-carboxylate

C13H23NO4 (257.1627)


   

Boc-alpha-Cyclohexyl-D-glycine

Boc-alpha-Cyclohexyl-D-glycine

C13H23NO4 (257.1627)


   

1-TERT-BUTYL 3-METHYL 3-METHYLPIPERIDINE-1,3-DICARBOXYLATE

1-TERT-BUTYL 3-METHYL 3-METHYLPIPERIDINE-1,3-DICARBOXYLATE

C13H23NO4 (257.1627)


   

tert-Butyl 3-(2-methoxy-2-oxoethyl)piperidine-1-carboxylate

tert-Butyl 3-(2-methoxy-2-oxoethyl)piperidine-1-carboxylate

C13H23NO4 (257.1627)


   

1-Tert-butyl 2-ethyl piperidine-1,2-dicarboxylate

1-Tert-butyl 2-ethyl piperidine-1,2-dicarboxylate

C13H23NO4 (257.1627)


   

2-(1-((TERT-BUTOXYCARBONYL)AMINO)CYCLOHEXYL)ACETIC ACID

2-(1-((TERT-BUTOXYCARBONYL)AMINO)CYCLOHEXYL)ACETIC ACID

C13H23NO4 (257.1627)


   

1-boc-4-ethyl-4-piperidinecarboxylic acid

1-boc-4-ethyl-4-piperidinecarboxylic acid

C13H23NO4 (257.1627)


   

(1R,2R)-ETHYL 2-((TERT-BUTOXYCARBONYL)AMINO)CYCLOPENTANECARBOXYLATE

(1R,2R)-ETHYL 2-((TERT-BUTOXYCARBONYL)AMINO)CYCLOPENTANECARBOXYLATE

C13H23NO4 (257.1627)


   

[1-(tert-butoxycarbonyl)-4-methylpiperidin-4-yl]acetic acid

[1-(tert-butoxycarbonyl)-4-methylpiperidin-4-yl]acetic acid

C13H23NO4 (257.1627)


   

Methyl trans-4-(tert-butoxycarbonylamino)cyclohexanecarboxylate

Methyl trans-4-(tert-butoxycarbonylamino)cyclohexanecarboxylate

C13H23NO4 (257.1627)


   

(3R,4R)-1-(TERT-BUTOXYCARBONYL)-4-ISOPROPYLPYRROLIDINE-3-CARBOXYLIC ACID

(3R,4R)-1-(TERT-BUTOXYCARBONYL)-4-ISOPROPYLPYRROLIDINE-3-CARBOXYLIC ACID

C13H23NO4 (257.1627)


   

(E)-3-hydroxy-4-oxo-3-[(trimethylazaniumyl)methyl]non-5-enoate

(E)-3-hydroxy-4-oxo-3-[(trimethylazaniumyl)methyl]non-5-enoate

C13H23NO4 (257.1627)


   

4-Hexenoylcarnitine

4-Hexenoylcarnitine

C13H23NO4 (257.1627)


   

(3E)-Hexenoylcarnitine

(3E)-Hexenoylcarnitine

C13H23NO4 (257.1627)


   

(2S)-N-Tert-butoxycarbonyl-2-(4-hydroxy-1-oxobutyl)pyrrolidine

(2S)-N-Tert-butoxycarbonyl-2-(4-hydroxy-1-oxobutyl)pyrrolidine

C13H23NO4 (257.1627)


   

2-Hexenoylcarnitine

2-Hexenoylcarnitine

C13H23NO4 (257.1627)


   

O-hexenoylcarnitine

O-hexenoylcarnitine

C13H23NO4 (257.1627)


An O-acyl carnitine in which the acyl group specified is hexenoyl.

   

O-hexenoyl-L-carnitine

O-hexenoyl-L-carnitine

C13H23NO4 (257.1627)


An O-acyl-L-carnitine in which the acyl group specified is hexenoyl in which the position of the double bond is unspecified.

   

3,7-dihydroxy-8-methyl-8-azabicyclo[3.2.1]octan-6-yl 2-methylbutanoate

3,7-dihydroxy-8-methyl-8-azabicyclo[3.2.1]octan-6-yl 2-methylbutanoate

C13H23NO4 (257.1627)